●●●○Moderate Evidence

Hyperbaric Therapy for PTSD

Military-funded research, Israeli Defense Forces studies, and what the evidence says about HBOT for post-traumatic stress.

Key Takeaways

  • PTSD affects 11–20% of Iraq and Afghanistan veterans and 6% of the general US population.
  • 30–40% of PTSD patients do not fully respond to standard treatments (CBT, EMDR, SSRIs).
  • Doenyas-Barak et al. (2022) showed improvement in treatment-resistant PTSD after HBOT at 2.0 ATA.
  • The US Department of Defense has funded multiple studies on HBOT for military PTSD.
  • PTSD frequently co-occurs with blast-induced TBI, complicating the evidence for HBOT's PTSD-specific effects.
  • HBOT is not FDA-approved for PTSD and is not standard VA treatment.

What is PTSD?

Post-traumatic stress disorder affects approximately 6% of the US population at some point in their lives, with significantly higher rates among military veterans (11–20% of Iraq and Afghanistan veterans). Standard treatments — cognitive behavioral therapy, EMDR, and medication (SSRIs) — leave approximately 30–40% of patients with residual symptoms. This treatment gap has driven interest in HBOT as an adjunct therapy, particularly in military medicine where PTSD often co-occurs with traumatic brain injury from blast exposure.

How Hyperbaric Therapy Helps PTSD

The connection between HBOT and PTSD is partly explained by the overlap with TBI — many veterans with PTSD also have blast-induced brain injuries that contribute to symptom severity. HBOT reduces neuroinflammation in brain regions associated with PTSD (amygdala, hippocampus, prefrontal cortex), improves cerebral blood flow to areas involved in emotional regulation and memory processing, and may promote neuroplasticity in trauma-affected neural circuits. Some researchers propose that HBOT helps create a "neurological foundation" that makes traditional PTSD therapies more effective by restoring function to brain regions that were previously too damaged or inflamed to respond to talk therapy.

Recommended Protocol

Pressure

1.5–2.0 ATA

Sessions

40–60 sessions

Duration

60 minutes per session

What Does the Evidence Say?

●●●○Moderate Evidence

Multiple studies have examined HBOT for PTSD, primarily in military populations. Harch et al. (2012) showed significant improvement in PTSD symptoms alongside cognitive improvements in veterans with blast-induced mTBI treated at 1.5 ATA. Doenyas-Barak et al. (2022) demonstrated improvement in treatment-resistant PTSD symptoms in Israeli veterans after HBOT at 2.0 ATA, with improvements in brain activity on functional MRI. The US Department of Defense has funded several HBOT-PTSD studies. However, separating the PTSD benefit from the TBI benefit remains challenging since the conditions frequently co-occur. The evidence is moderate and growing, particularly for PTSD with comorbid TBI.

Off-Label Use

PTSD is not an FDA-approved indication for HBOT. Treatment is considered off-label and is typically not covered by insurance. Consult your physician before starting any HBOT protocol.

Recommended Chambers for PTSD

Based on the protocol requirements — minimum 1.5 ATA, Clinical Grade or Advanced Wellness tier. Sorted by clinical credibility score.

Multiplace Series hyperbaric chamber
Clinical GradeFDA Cleared
For Wound Care

Perry Baromedical

Multiplace Series

Hard-Shell Multiplace·2-18+ person
Pressure3 ATA

$150,000 - $400,000+

Custom multiplace chambers from 2 to 18+ patients. 3.0 ATA. The gold standard for hospital multiplace HBOT.

Sigma 34 hyperbaric chamber
Clinical GradeFDA Cleared
For Wound Care

Perry Baromedical

Sigma 34

Hard-Shell Monoplace·1-person
Pressure3 ATA

$50,000 - $90,000

Clinical monoplace chamber at 3.0 ATA. 33.5-inch diameter. The standard for hospital HBOT worldwide since 1956.

Sigma 36 hyperbaric chamber
Clinical GradeFDA Cleared
For Wound Care

Perry Baromedical

Sigma 36

Hard-Shell Monoplace·1-person
Pressure3 ATA

$55,000 - $95,000

Wider monoplace at 36-inch diameter. 3.0 ATA. More patient comfort than Sigma 34.

Sigma 40 hyperbaric chamber
Clinical GradeFDA Cleared
For Maximum Comfort

Perry Baromedical

Sigma 40

Hard-Shell Monoplace·1-person
Pressure3 ATA

$65,000 - $110,000

Largest monoplace chamber in the world at 40.5-inch diameter. 3.0 ATA. Maximum patient comfort.

Sigma 40-II hyperbaric chamber
Clinical GradeFDA Cleared
For Wound Care

Perry Baromedical

Sigma 40-II

Hard-Shell Multiplace·2-person
Pressure3 ATA

$100,000 - $160,000

Dual-place chamber treating 2 patients simultaneously. 40.5-inch diameter, 3.0 ATA with BIBS/Duke hoods.

Sigma Elite hyperbaric chamber
Clinical GradeFDA Cleared
For Wound Care

Perry Baromedical

Sigma Elite

Hard-Shell Monoplace·1-person
Pressure3 ATA

$80,000 - $130,000

Perry's flagship monoplace with touch-screen electronic controls and EMR integration. 3.0 ATA.

Frequently Asked Questions

Does the VA offer HBOT for PTSD?

The VA has funded multiple HBOT-PTSD research studies and some VA facilities offer HBOT on a case-by-case basis, but it is not a standard VA treatment for PTSD. Coverage depends on the specific VA facility and whether the veteran qualifies for a research protocol. Several veteran advocacy organizations are pushing for broader VA adoption.

Can HBOT replace traditional PTSD therapy?

No. HBOT should be considered an adjunct to, not a replacement for, evidence-based PTSD treatments like CBT, EMDR, and medication. The most promising approach appears to be combining HBOT with traditional therapy — the neurological improvements from HBOT may make patients more responsive to psychological interventions.

Is PTSD-related HBOT different from TBI protocols?

The protocols are very similar because PTSD and TBI frequently co-occur and share neuroinflammatory mechanisms. Most studies use 1.5–2.0 ATA for 40–60 sessions. Some researchers are exploring whether PTSD-specific protocols (targeting different session counts or combined with therapy) might be more effective.

Related Conditions

Sources & References

  1. Doenyas-Barak et al. (2022) — Hyperbaric oxygen therapy for veterans with treatment-resistant PTSD, Military Medicine
  2. Harch et al. (2012) — A phase I study of low-pressure HBOT for blast-induced PTSD, Journal of Neurotrauma
  3. US Department of Veterans Affairs — PTSD: National Center for PTSD
  4. Hadanny et al. (2022) — Brain MRI changes after HBOT for PTSD, PLOS ONE

Last updated: March 2026. Data sourced from manufacturer specifications, FDA databases, and published clinical research.

Ready to compare chambers?

Use our filterable directory to find chambers that match your protocol requirements.